CLINICAL DEVELOPMENT OF ANTICANCER AGENTS

抗癌药物的临床开发

• 批准号: 3613338
• 负责人: IRWIN H KRAKOFF
• 金额: $ 14.25万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 1985
• 资助国家: 美国
• 起止时间: 1985-09-01 至 1990-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3613338
• 关键词: bioassay; chemical information system; dosage; drug adverse effect; drug hypersensitivity; drug metabolism; drug quality /standard; human therapy evaluation; mass spectrometry; neoplasm /cancer pharmacology; nuclear magnetic resonance spectroscopy; prognosis